← Back
Data updated: Mar 10, 2026
USPHARMA
NeurologyOncologyImmunology
USPHARMA is a pharmaceutical company focused on Neurology, Oncology, Immunology.
1985
Since
2
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 36%
0 drugs Phase 3: 2 Phase 2: 11 Phase 1: 4
Oncology 21%
0 drugs Phase 3: 1 Phase 2: 2 Phase 1: 12
Immunology 18%
0 drugs Phase 3: 3 Phase 2: 2 Phase 1: 1
Gastroenterology 14%
0 drugs Phase 3: 2 Phase 1: 5
Ophthalmology 11%
0 drugs Phase 2: 5
Pipeline Strength Pro
Loading...
Competitors Pro
AbbVie big-pharma
Immunology, Oncology, Neurology, Ophthalmology
Roche big-pharma
Oncology, Neurology, Ophthalmology, Immunology
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology